查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1662624

2030 年肠外营养市场预测：按产品类型、营养类型、给药途径、应用、最终用户和地区进行的全球分析

Parenteral Nutrition Market Forecasts to 2030 - Global Analysis By Product Type (Total Parenteral Nutrition (TPN) and Partial Parenteral Nutrition (PPN)), Nutrient Type, Route of Administration, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2024 年全球肠外营养市场价值为 75 亿美元，预计到 2030 年将达到 114 亿美元，预测期内的复合年增长率为 7.0%。

肠外营养（PN）是一种绕过消化器官系统将必需营养素直接输送到血液的治疗方法。它通常用于因胃肠道疾病、手术或严重营养不良等情况而无法从正常饮食中吸收营养的患者。 PN 透过静脉注射提供客製化的碳水化合物、蛋白质、脂质、维生素和矿物质混合物，以确保患者获得足够的营养来恢復和维持身体功能。根据患者的需要，可以提供短期或长期的营养支持。

根据美国疾病管制与预防中心（ 美国）的数据，2022 年全国早产率约为 10.4%。同一时期，非裔美国女性的早产率约为 14.6%。

慢性病盛行率上升

癌症、糖尿病和胃肠道疾病等慢性病的发生率上升正在推动市场的成长。这些疾病通常会损害营养吸收，需要静脉营养支持。随着越来越多的患者需要客製化的营养补充来控制营养不良和康復，对肠外营养解决方案的需求正在增长。这一趋势正在推动配方创新并扩大市场以改善患者的治疗效果。

报销范围有限

肠外营养的保险报销有限是一个重大的市场挑战，限制了许多需要长期营养支持的患者获得营养支持。保险报销不足会导致高昂的自付费用，使治疗成为经济负担。这限制了获得基本护理的机会，尤其是对于患有慢性病的患者和居家医疗的患者。由于缺乏足够的保险覆盖，导致治疗延迟，对患者的治疗结果产生负面影响。

居家医疗需求不断增加

居家医疗需求的不断增长促进了市场的扩大。需要长期营养支持的患者越来越多地在家中接受护理，从而减少了住院时间和医疗费用。可携式输液帮浦和改良剂型等家庭用药的进步使得病人用药更加安全方便。这种向居家医疗的转变加速了慢性病患者采用肠外营养。

肠外营养成本高昂

肠外营养 (PN) 的高成本是其广泛应用的重大障碍，尤其是对于保险不足的患者而言。治疗费用高昂，包括专门的配方、设备和医疗支持，给患者和医疗保健系统带来了经济负担。这可能会导致获得医疗护理的延迟或限制，特别是对于低收入人群，最终影响患者的治疗结果并扩大医疗保健差距。

COVID-19 的影响

COVID-19 疫情对市场产生了重大影响，由于 COVID-19 患者的严重营养不良和胃肠道併发症增加，需求增加。随着医疗保健系统将重点转向重症加护，医院变得不堪重负，对家庭 PN 的需求也随之增加。然而，供应链中断和关键原料的短缺最初影响了可得性。儘管有这些挑战，疫情加速了采用居家医疗解决方案来提供长期营养支持。

预计预测期内氨基酸部分将以最快的速度成长。

预计预测期内胺基酸部分将占据最大的市场占有率，因为胺基酸是蛋白质合成和整体身体功能的必需成分。在配方中，胺基酸透过静脉注射来支持无法口服吸收营养的患者。客製化胺基酸解决方案可根据个人的特定需求，特别是患有慢性疾病的人的特定需求而量身定制，以确保适当的恢復，维持肌肉质量并防止营养不良。

预计预测期内医院部门将以最高的复合年增长率成长。

预计预测期内医院部门将呈现最高的成长率。医院是向严重营养不良、胃肠道疾病患者以及手术后康復患者提供药物的主要场所。在医院里，使用特殊製剂来满足无法口服吸收营养的重症患者的营养需求。需要营养支持的慢性和复杂疾病的发生率不断上升，并持续推动医院的需求。

比最大的地区

在预测期内，由于慢性病盛行率上升、人口老化以及对居家医疗解决方案的需求不断增加，预计北美将占据最大的市场占有率。该地区先进的医疗基础设施以及 PN 配方和给药方法的创新进一步推动了市场扩张。此外，强有力的报销政策和对改善患者治疗效果的关注也促进了该地区的采用率不断提高。

复合年增长率最高的地区

预计预测期内亚太地区将呈现最高的复合年增长率。随着诊断工具的改进和对营养在各种医疗状况管理中的重要性的理解不断加深，医疗保健行业对肠外营养的认识也日益加深。此外，该地区的一些政府正致力于改善医疗保健和营养的机会，特别是在开发中国家。这为市场成长创造了有利的环境。

免费客製化服务

订阅此报告的客户可享有以下免费自订选项之一：

  • 公司简介
    • 对其他市场参与企业（最多 3 家公司）进行全面分析
    • 主要企业的 SWOT 分析（最多 3 家公司）
  • 地理细分
    • 根据客户兴趣对主要国家进行市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争性基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第 2 章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二手研究资料资讯来源
    • 先决条件

第三章 市场走势分析

  • 介绍
  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第 4 章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球肠外营养市场依产品类型划分

  • 介绍
  • 全静脉营养（TPN）
  • 部分肠外营养 (PPN)

6. 全球肠外营养市场依营养类型划分

  • 介绍
  • 胺基酸
  • 碳水化合物
  • 脂质
  • 维生素和矿物质
  • 微量元素

7. 全球肠外营养市场依给药途径划分

  • 介绍
  • 完全肠外营养（CPN）
  • 周边静脉营养（PPN）

8. 全球肠外营养市场（依应用）

  • 介绍
  • 癌症
  • 胃肠道疾病
  • 神经系统疾病
  • 加护治疗
  • 小儿科/新生儿
  • 肝臟疾病
  • 其他的

9. 全球肠外营养市场（依最终用户划分）

  • 介绍
  • 医院
  • 居家医疗
  • 长期照护机构
  • 其他的

第 10 章。

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • AbbVie Inc.
  • Baxter International Inc.
  • Merck & Co.
  • Danone Nutricia
  • Medi Pharma
  • Eli Lilly and Company
  • Aptalis Pharma
  • Sodium Bicarbonate LLC
  • Biomarin Pharmaceutical
  • B. Braun Melsungen AG
  • Smith & Nephew
  • Roche Holding AG
  • Novartis International AG
  • Medtronic
  • Orion Corporation
Product Code: SMRC28485

According to Stratistics MRC, the Global Parenteral Nutrition Market is accounted for $7.5 billion in 2024 and is expected to reach $11.4 billion by 2030 growing at a CAGR of 7.0% during the forecast period. Parenteral nutrition (PN) is a medical treatment that provides essential nutrients directly into the bloodstream, bypassing the digestive system. This is typically used for patients who cannot absorb nutrients through normal eating due to conditions like gastrointestinal disorders, surgeries, or severe malnutrition. PN delivers a customized mixture of carbohydrates, proteins, fats, vitamins, and minerals through an intravenous line, ensuring the patient receives adequate nutrition for recovery and maintenance of body functions. It can be short-term or long-term depending on the patient's needs.

According to the U.S. Centers for Disease Control and Prevention (CDC), the preterm birth rate in the country was approximately 10.4% in 2022. In addition, during the same period, the preterm birth rate for African American women was around 14.6%.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases

The rising prevalence of chronic diseases, such as cancer, diabetes, and gastrointestinal disorders, is driving the growth of the market. These conditions often impair nutrient absorption, necessitating intravenous nutrient support. As more patients require tailored nutrition to manage malnutrition and recovery, the demand for parenteral nutrition solutions increases. This trend is prompting innovations in the formulations and improving patient outcomes, thus expanding the market.

Restraint:

Limited reimbursement coverage

Limited reimbursement coverage for parenteral nutrition presents a significant challenge in the market, hindering access for many patients who need long-term nutritional support. Insufficient insurance reimbursement can lead to high out-of-pocket costs, making the treatment financially burdensome. This restricts patient access to essential care, particularly for those with chronic illnesses or in home healthcare settings. Consequently, the lack of adequate coverage can delay treatment and negatively impact patient outcomes.

Opportunity:

Growing demand for home healthcare

The growing demand for home healthcare is contributing to the expansion of the market. Patients requiring long-term nutritional support are increasingly being treated at home, reducing hospital stays and healthcare costs. Advances in home administration, including portable infusion pumps and improved formulations, are making it safer and more convenient for patients. This shift toward home healthcare is driving greater adoption of parenteral nutrition among individuals with chronic conditions.

Threat:

High cost of parenteral nutrition

The high cost of parenteral nutrition (PN) poses a significant barrier to its widespread adoption, particularly for patients without adequate insurance coverage. The expensive nature of the treatments, including specialized formulas, equipment, and healthcare support, can lead to financial strain on patients and healthcare systems. This can result in delayed treatments or limited access, especially in low-income populations, ultimately affecting patient outcomes and increasing healthcare disparities.

Covid-19 Impact:

The COVID-19 pandemic had a profound impact on the market, increasing demand due to the rise in severe malnutrition and gastrointestinal complications among COVID-19 patients. The healthcare system's focus on critical care further heightened the need for home-based PN as hospitals were overwhelmed. However, disruptions in supply chains and shortages of key ingredients initially affected availability. Despite these challenges, the pandemic accelerated the adoption of home healthcare solutions for long-term nutritional support.

The amino acids segment is expected to be the largest during the forecast period

The amino acids segment is expected to account for the largest market share during the forecast period as they are essential building blocks for protein synthesis and overall body function. In formulations, amino acids are provided intravenously to support patients who cannot absorb nutrients orally. Customized amino acid solutions are tailored to meet the specific needs of individuals, especially those with chronic conditions, ensuring proper recovery, maintaining muscle mass, and preventing malnutrition.

The hospitals segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the hospitals segment is predicted to witness the highest growth rate as they are primary settings for administering to patients with severe malnutrition, gastrointestinal disorders, or recovery from surgeries. Hospitals use specialized formulations to meet the nutritional needs of critically ill patients who cannot absorb nutrients orally. The demand in hospitals continues to grow due to the increasing prevalence of chronic diseases and complex medical conditions requiring nutritional support.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share driven by the rising prevalence of chronic diseases, an aging population, and increasing demand for home healthcare solutions. The region's advanced healthcare infrastructure, along with innovations in PN formulations and delivery methods, further fuels market expansion. Additionally, strong reimbursement policies and a focus on improving patient outcomes are contributing to the growing adoption in the region.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. There is growing awareness of parenteral nutrition in the healthcare community, with better diagnostic tools and a rising understanding of the importance of nutrition in managing various medical conditions. Additionally, several governments in the region are focusing on improving healthcare access and nutrition, especially in developing countries. This creates a conducive environment for the growth of the market.

Key players in the market

Some of the key players in Parenteral Nutrition market include AbbVie Inc., Baxter International Inc., Merck & Co., Danone Nutricia, Medi Pharma, Eli Lilly and Company, Aptalis Pharma, Sodium Bicarbonate LLC, Biomarin Pharmaceutical, B. Braun Melsungen AG, Smith & Nephew, Roche Holding AG, Novartis International AG, Medtronic and Orion Corporation.

Key Developments:

In June 2024, AbbVie and FutureGen Biopharmaceutical (Beijing) Co., Ltd. announced a license agreement to develop FG-M701, a next generation TL1A antibody for the treatment of IBD currently in preclinical development.

In May 2024, Baxter International Inc. (NYSE:BAX), a global leader in nutrition therapy, announced U.S. FDA approval of an expanded indication for Clinolipid (Lipid Injectable Emulsion) to be used in pediatric patients, including preterm and term neonates.

Product Types Covered:

  • Total Parenteral Nutrition (TPN)
  • Partial Parenteral Nutrition (PPN)

Nutrient Types Covered:

  • Amino Acids
  • Carbohydrates
  • Lipids
  • Vitamins & Minerals
  • Trace Elements

Route of Administrations Covered:

  • Central Parenteral Nutrition (CPN)
  • Peripheral Parenteral Nutrition (PPN)

Applications Covered:

  • Cancer
  • Gastrointestinal Disorders
  • Neurological Disorders
  • Critical Care
  • Pediatrics/Neonates
  • Liver Disease
  • Other Applications

End Users Covered:

  • Hospitals
  • Homecare
  • Long-Term Care Facilities
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Parenteral Nutrition Market, By Product Type

  • 5.1 Introduction
  • 5.2 Total Parenteral Nutrition (TPN)
  • 5.3 Partial Parenteral Nutrition (PPN)

6 Global Parenteral Nutrition Market, By Nutrient Type

  • 6.1 Introduction
  • 6.2 Amino Acids
  • 6.3 Carbohydrates
  • 6.4 Lipids
  • 6.5 Vitamins & Minerals
  • 6.6 Trace Elements

7 Global Parenteral Nutrition Market, By Route of Administration

  • 7.1 Introduction
  • 7.2 Central Parenteral Nutrition (CPN)
  • 7.3 Peripheral Parenteral Nutrition (PPN)

8 Global Parenteral Nutrition Market, By Application

  • 8.1 Introduction
  • 8.2 Cancer
  • 8.3 Gastrointestinal Disorders
  • 8.4 Neurological Disorders
  • 8.5 Critical Care
  • 8.6 Pediatrics/Neonates
  • 8.7 Liver Disease
  • 8.8 Other Applications

9 Global Parenteral Nutrition Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Homecare
  • 9.4 Long-Term Care Facilities
  • 9.5 Other End Users

10 Global Parenteral Nutrition Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 AbbVie Inc.
  • 12.2 Baxter International Inc.
  • 12.3 Merck & Co.
  • 12.4 Danone Nutricia
  • 12.5 Medi Pharma
  • 12.6 Eli Lilly and Company
  • 12.7 Aptalis Pharma
  • 12.8 Sodium Bicarbonate LLC
  • 12.9 Biomarin Pharmaceutical
  • 12.10 B. Braun Melsungen AG
  • 12.11 Smith & Nephew
  • 12.12 Roche Holding AG
  • 12.13 Novartis International AG
  • 12.14 Medtronic
  • 12.15 Orion Corporation

List of Tables

  • Table 1 Global Parenteral Nutrition Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Parenteral Nutrition Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 3 Global Parenteral Nutrition Market Outlook, By Total Parenteral Nutrition (TPN) (2022-2030) ($MN)
  • Table 4 Global Parenteral Nutrition Market Outlook, By Partial Parenteral Nutrition (PPN) (2022-2030) ($MN)
  • Table 5 Global Parenteral Nutrition Market Outlook, By Nutrient Type (2022-2030) ($MN)
  • Table 6 Global Parenteral Nutrition Market Outlook, By Amino Acids (2022-2030) ($MN)
  • Table 7 Global Parenteral Nutrition Market Outlook, By Carbohydrates (2022-2030) ($MN)
  • Table 8 Global Parenteral Nutrition Market Outlook, By Lipids (2022-2030) ($MN)
  • Table 9 Global Parenteral Nutrition Market Outlook, By Vitamins & Minerals (2022-2030) ($MN)
  • Table 10 Global Parenteral Nutrition Market Outlook, By Trace Elements (2022-2030) ($MN)
  • Table 11 Global Parenteral Nutrition Market Outlook, By Route of Administration (2022-2030) ($MN)
  • Table 12 Global Parenteral Nutrition Market Outlook, By Central Parenteral Nutrition (CPN) (2022-2030) ($MN)
  • Table 13 Global Parenteral Nutrition Market Outlook, By Peripheral Parenteral Nutrition (PPN) (2022-2030) ($MN)
  • Table 14 Global Parenteral Nutrition Market Outlook, By Application (2022-2030) ($MN)
  • Table 15 Global Parenteral Nutrition Market Outlook, By Cancer (2022-2030) ($MN)
  • Table 16 Global Parenteral Nutrition Market Outlook, By Gastrointestinal Disorders (2022-2030) ($MN)
  • Table 17 Global Parenteral Nutrition Market Outlook, By Neurological Disorders (2022-2030) ($MN)
  • Table 18 Global Parenteral Nutrition Market Outlook, By Critical Care (2022-2030) ($MN)
  • Table 19 Global Parenteral Nutrition Market Outlook, By Pediatrics/Neonates (2022-2030) ($MN)
  • Table 20 Global Parenteral Nutrition Market Outlook, By Liver Disease (2022-2030) ($MN)
  • Table 21 Global Parenteral Nutrition Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 22 Global Parenteral Nutrition Market Outlook, By End User (2022-2030) ($MN)
  • Table 23 Global Parenteral Nutrition Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 24 Global Parenteral Nutrition Market Outlook, By Homecare (2022-2030) ($MN)
  • Table 25 Global Parenteral Nutrition Market Outlook, By Long-Term Care Facilities (2022-2030) ($MN)
  • Table 26 Global Parenteral Nutrition Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.